Estrella Immunopharma, Inc. Quarterly Liabilities, Current in USD from Q3 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Estrella Immunopharma, Inc. quarterly Liabilities, Current history and growth rate from Q3 2021 to Q3 2024.
  • Estrella Immunopharma, Inc. Liabilities, Current for the quarter ending September 30, 2024 was $2.99M, a 82.7% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.99M -$14.3M -82.7% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $181K -$9.58M -98.1% Jun 30, 2024 10-Q 2024-11-14
Q1 2024 $138K -$1.08M -88.6% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $399K -$674K -62.8% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 $17.3M +$16.5M +2249% Sep 30, 2023 10-Q 2023-11-20
Q2 2023 $9.76M +$9.6M +6210% Jun 30, 2023 10-K 2024-09-27
Q1 2023 $1.22M +$1.19M +3925% Mar 31, 2023 10-Q 2023-05-18
Q4 2022 $1.07M +$1M +1367% Dec 31, 2022 10-Q 2023-08-01
Q3 2022 $736K +$635K +631% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $155K Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $30.2K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $73.2K Dec 31, 2021 10-K 2023-03-14
Q3 2021 $101K Sep 30, 2021 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.